Article Versions Notes

Thornhill-Wadolowski E, Ruter DL, Yan F, Gajera M, Kurt E, Samanta L, Leigh K, Zhu J, Guo Z, Wang Z, et al. Development of an Influenza/COVID-19 Combination mRNA Vaccine Containing a Novel Multivalent Antigen Design That Enhances Immunogenicity of Influenza Virus B Hemagglutinins. Vaccines. 2025; 13(6):628. https://doi.org/10.3390/vaccines13060628

Thornhill-Wadolowski, Elena, Dana L. Ruter, Feng Yan, Mayur Gajera, Evan Kurt, Labannya Samanta, Kimberlin Leigh, Jianbo Zhu, Zhijun Guo, Zihao Wang, and et al. 2025. "Development of an Influenza/COVID-19 Combination mRNA Vaccine Containing a Novel Multivalent Antigen Design That Enhances Immunogenicity of Influenza Virus B Hemagglutinins" Vaccines 13, no. 6: 628. https://doi.org/10.3390/vaccines13060628

Thornhill-Wadolowski, E., Ruter, D. L., Yan, F., Gajera, M., Kurt, E., Samanta, L., Leigh, K., Zhu, J., Guo, Z., Wang, Z., Liu, Y., Lee, J., & Bugno, M. (2025). Development of an Influenza/COVID-19 Combination mRNA Vaccine Containing a Novel Multivalent Antigen Design That Enhances Immunogenicity of Influenza Virus B Hemagglutinins. Vaccines, 13(6), 628. https://doi.org/10.3390/vaccines13060628